TYRA vs URGN Stock Comparison

URGN currently leads TYRA in this stock comparison, with AIQ scores of 53 vs 49. The clearest difference is momentum, while TYRA has the stronger quality profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 4 points
TYRA
Healthcare
vs
URGN
Healthcare
TYRA
Tyra Biosciences, Inc.
Price
$20.03
Day move
+1.32%
AIQ Score
49/100
Best edge
Quality
Sector
Healthcare
URGN
UroGen Pharma Ltd.
Leads
Price
$26.18
Day move
-0.8%
AIQ Score
53/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between TYRA and URGN?

URGN leads the current stock comparison as UroGen Pharma Ltd., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Tyra Biosciences, Inc. vs UroGen Pharma Ltd.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

URGN leads

URGN leads by 4 AIQ points, primarily on Momentum, but the lead has narrowed from 23 points over 30 sessions.

Fragile: 3 of 5 evidence groups support URGN, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Weakening
TYRA

Tyra Biosciences, Inc.

AIQ Score
49/100
AIQ Edge Score
8/10
URGN

UroGen Pharma Ltd.

Leads
AIQ Score
53/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors URGN over TYRA, 53 versus 49 as of Nov 15, 2026. URGN's advantage is driven primarily by stronger momentum, while TYRA holds the stronger quality profile. URGN also shows the weaker technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor URGN today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 4 points. URGN lead: Weakening — the AIQ differential moved from 23 to 4 points over 30 sessions.

Compare Tyra Biosciences, Inc. and UroGen Pharma Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

TYRA
-25.3%
URGN
+100.5%

Price return comparison

Growth of $10,000, price only

TYRA $7,475 · URGN $20,046

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare TYRA and URGN against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

TYRA advantage
0
URGN advantage
  • Momentum27 vs 40
    URGN +13
  • Quality75 vs 68
    TYRA +7
  • Risk Resilience45 vs 40
    TYRA +5

3 of 5 evidence groups favor URGN. URGN’s edge is concentrated in momentum; TYRA keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

TYRA-1 AIQ

Largest factor move: Momentum -3

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
URGN0 AIQ

Largest factor move: Value +2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 5 active signals are unchanged.

URGN's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — TYRA and URGN both carry a full feed there.

The central trade-off

URGN (UroGen Pharma Ltd.): the stronger current systematic profile, led by momentum.

TYRA (Tyra Biosciences, Inc.): the counter-case, on quality, risk resilience, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

URGN

URGN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

URGN

URGN on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

URGN

URGN on the Momentum factor, by 13 points.

Lower downside

TYRA

TYRA on Risk Resilience, by 5 points.

Analyst upside

URGN

URGN on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureTYRAURGNNote
Implied upside to target+118.5%+121.5%URGN has more room
Target dispersion+61.7%+6.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering158Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor URGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreURGN49 vs 53
FundamentalsURGNEPS growth -7.2% vs 89.3%; TTM ROE -7.4% vs 1.2%
ValuationNot coveredNot covered
TechnicalsTYRAPrice vs 50-day -7.9% vs -29.2%; vs 200-day -31.9% vs -17.4%
Risk ResilienceTYRARisk Resilience 45 vs 40
Analyst expectationsURGNTarget upside 118.5% vs 121.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of TYRA and URGN and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 4 points. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on URGN.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

URGN lead: Weakening — the AIQ differential moved from 23 to 4 points over 30 sessions.

May 27TYRA leads above the line · URGN leads belowNov 13
Today
URGN +4
49 vs 53
7 sessions ago
URGN +12
45 vs 57
30 sessions ago
URGN +23
40 vs 63
90 sessions ago
URGN +20
50 vs 70

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

TYRA

0 bullish / 5 bearish / 2 neutral

Only TYRA

  • Death Cross Active — bearish, trend, long horizon (35.22%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
URGNConflicted

2 bullish / 1 bearish / 2 neutral, conflicted

Only URGN

  • Golden Cross Active — bullish, trend, long horizon (16.77%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • RSI Oversold — bullish, momentum, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

URGN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

TYRADivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +1.32%, AIQ -1 points).

URGNNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.8%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1TYRA closes the Momentum gap — currently 13 points behind, the largest single contributor to URGN's edge.
  2. 2TYRA's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3URGN's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 19 points over 30 sessions, and a further 4-point move would eliminate URGN's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

URGN leads on balance
MetricTYRAURGN
Revenue growth (YoY)0%22.8%
EPS growth (YoY)-7.2%89.3%
Gross margin0%91.4%
Operating margin0%-12.4%
Return on equity (TTM)-7.4%1.2%
Debt to equity0.01-1.57

Performance

Split across windows
MetricTYRAURGN
1 week (5 sessions)-5.3%5.8%
1 month (20 sessions)8.1%-24.2%
3 months (63 sessions)-23.6%-46.7%
6 months (126 sessions)-45.9%-9%
Year to date-23.8%11.8%
1 year (252 sessions)29.4%4.1%

Technicals

TYRA has the stronger structure
MetricTYRAURGN
RSI (14)42.828.7
ADX (14)12.145.1
Price vs 50-day-7.9%-29.2%
Price vs 200-day-31.9%-17.4%
Volatility (1M, annualized)51.8%79.4%

Risk

TYRA is the more resilient
MetricTYRAURGN
Beta0.531.33
Sharpe ratio0.650.39
Sortino ratio10.56
Max drawdown-53.2%-50.8%
Current drawdown-49.4%-47.9%
Annualized volatility67.9%61.9%
Value at risk (95%)-5.3%-5.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, TYRA or URGN?

On the Algovestiq AIQ Score, URGN is the stronger of the two as of Nov 15, 2026, scoring 53 against TYRA's 49. The edge comes from momentum. TYRA is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is TYRA or URGN the better buy right now?

URGN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 4 points. Treat the lead as provisional.

Why does the AIQ Score favor URGN over TYRA?

The composite weights Quality, Value, Momentum and Risk Resilience. URGN leads Momentum by 13 points; TYRA leads Quality by 7 points; TYRA leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, TYRA or URGN?

Analyst price targets imply +118.5% upside for TYRA and +121.5% for URGN, so the Street currently favors URGN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, TYRA or URGN?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, TYRA or URGN?

URGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, TYRA or URGN?

URGN on the Momentum factor, by 13 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, TYRA or URGN?

TYRA is the more resilient of the two, so the other name carries the higher downside risk. TYRA on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is TYRA more profitable than URGN?

URGN leads on the comparable margin measures — gross margin 0% vs 91.4%; operating margin 0% vs -12.4%; ttm roe -7.4% vs 1.2%.

Is URGN's lead over TYRA getting stronger or weaker?

URGN lead: Weakening — the AIQ differential moved from 23 to 4 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the TYRA vs URGN verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TYRA closes the Momentum gap — currently 13 points behind, the largest single contributor to URGN's edge; TYRA's Death Cross Active resolves — a bearish trend rule currently active against it; URGN's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 19 points over 30 sessions, and a further 4-point move would eliminate URGN's advantage entirely.

What do the current signals say about TYRA and URGN?

TYRA: 0 bullish / 5 bearish / 2 neutral. URGN: 2 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on TYRA is Death Cross Active (bearish, long horizon). On URGN it is Golden Cross Active (bullish, long horizon).

Compare TYRA and URGN with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.